BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 7, 2016
View Archived Issues
Apeptico and Mediolanum sign a cooperation and license agreement for solnatide
Read More
Amgen and Allergan submit MAA for bevacizumab biosimilar
Read More
Ferring Pharmaceuticals and MetaboGen enter research collaboration
Read More
Noveome Biotherapeutics begins phase II study of ST-266
Read More
BFORE study of bosutinib in CML meets primary endpoint
Read More
Purdue Pharma, AnaBios to study compounds for chronic pain
Read More
Calimmune and Cincinnati Children's Hospital Medical Center to work together on gene therapies
Read More
NeuroDerm gives update on ND-0612 regulatory path
Read More
Matinas BioPharma initiates dosing in phase I study of MAT-2501
Read More
Adaptimmune starts study of NY-ESO SPEAR-engineered T cells in myxoid/round cell liposarcoma
Read More
Promising phase I data presented for SEP-363856 in schizophrenia
Read More
Phase II data for verinurad plus febuxostat in patients with gout and asymptomatic hyperuricemia
Read More
Omeros provides continued access to OMS-721 for patient with HSCT-TMA
Read More
Novo Nordisk submits applications in E.U., U.S. for semaglutide
Read More
Sanofi Genzyme begins phase III study of isatuximab
Read More
Anti-APRIL monoclonal antibody developed at Visterra for IgA nephropathy
Read More
Novogen initiates phase I study of Cantrixil in ovarian cancer
Read More
TherapeuticsMD discloses topline results from Replenish trial of TX-001HR
Read More
VCN Biosciences' adenovirus expressing hyaluronidase: first clinical data
Read More
Further phase I data reported for DS-6051b in patients with solid tumors
Read More
Sage expedites development of SAGE-547 for postpartum depression
Read More
FDA grants fast track designation to Neovacs' IFN-alpha kinoid in lupus
Read More
Harvard College divulges novel CDK8 and/or CDK19 inhibitors
Read More
European Commission approves Lucentis for sixth indication
Read More
Takeda describes new Toll-like receptor 4 antagonists
Read More
The University of Athens identifies novel E-NPP 2 inhibitors
Read More
Beijing Institute of Pharmacology and Toxicology patents CB1 receptor antagonists
Read More
Shanghai Institute Materia Medica presents new c-Met inhibitors
Read More
FDA approves Avastin for platinum-sensitive ovarian cancer
Read More
WHO recommends seladelpar as INN for CymaBay's MBX-8025
Read More